BioMarin Updates Timing of First Quarter 2020 Financial Results Conference Call and Webcast to Wednesday, April 29 at 4:15pm ET

SAN RAFAEL, Calif., April 22, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, April 29, at 4:15 p.m. ET to discuss first quarter 2020 financial results and provide a general business update. The timing of the call has been modified to increase the ability of our investors and analysts to participate.

Dial-in Number U.S. / Canada Dial-in Number: (833) 360-0852International Dial-in Number: (630) 652-5841Conference ID: 6194595

Replay Dial-in Number: (855) 859-2056Replay International Dial-in Number: (404) 537-3406Conference ID: 6194595

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.biomarin.com. A replay of the call will be archived on the site for one week following the call.

About BioMarinBioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-updates-timing-of-first-quarter-2020-financial-results-conference-call-and-webcast-to-wednesday-april-29-at-415pm-et-301044737.html

SOURCE BioMarin Pharmaceutical Inc.